Brighton Jones LLC’s Journey Medical DERM Stock Holding History

Brighton Jones LLC’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.9K	Buy	12,702 +266	+2%	+$1.52K	﹤0.01%	1319
2026 Q1	$58.3K	Buy	+12,436	New	+$96.5K	﹤0.01%	1156
2025 Q4	–	Sell	-16,842	Closed	-$120K	–	260
2025 Q3	$120K	Buy	16,842 +22	+0.1%	+$160	﹤0.01%	986
2025 Q2	$121K	Sell	16,820 -6,200	-27%	-$42.8K	﹤0.01%	885
2025 Q1	$136K	Hold	23,020	–	–	﹤0.01%	673
2024 Q4	$90K	Hold	23,020	–	–	﹤0.01%	663
2024 Q3	$130K	Hold	23,020	–	–	﹤0.01%	555
2024 Q2	$130K	Hold	23,020	–	–	﹤0.01%	598
2024 Q1	$84.7K	Hold	23,020	–	–	﹤0.01%	613
2023 Q4	$133K	Hold	23,020	–	–	0.01%	558
2023 Q3	$63.1K	Hold	23,020	–	–	﹤0.01%	531
2023 Q2	$36.6K	Buy	+23,020	New	+$37K	﹤0.01%	538

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.48% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Brighton Jones LLC's DERM Position: Q2 2026 in Review

Brighton Jones LLC increased its Journey Medical (DERM) stake by 2.1% in Q2 2026, buying an estimated $1.52K and bringing the position to 12,702 shares worth $89.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

Brighton Jones LLC first reported a position in DERM in Q2 2023 and has held it in 12 quarters since. The position peaked at $136K in Q1 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Brighton Jones LLC held 12,702 shares of Journey Medical worth $89.9K as of Q2 2026.
Brighton Jones LLC bought 266 Journey Medical shares in Q2 2026, an estimated $1.52K.
Journey Medical made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1319 holding.
Brighton Jones LLC first reported a position in Journey Medical in Q2 2023 and has held it in 12 quarters since.
Brighton Jones LLC's Journey Medical position peaked at $136K in Q1 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.